key: cord-0950432-r7z4eeh1
authors: Malek, Ines; Sayadi, Jihene; Lahiani, Rim; Boumediene, Miriam; Salah, Memia Ben; Jrad, Myriam; Khairallah, Moncef; Nacef, Leila
title: Acute bilateral blindness in a young Covid-19 patient with rhino-orbito-cerebral mucormycosis
date: 2021-10-18
journal: J Ophthalmic Inflamm Infect
DOI: 10.1186/s12348-021-00272-0
sha: a684fa5b03e1e7ba26deb904297e03b8b4bb11a7
doc_id: 950432
cord_uid: r7z4eeh1

nan

The patient was started on intra-venous liposomal amphotericin B and clavulanic-acid-amoxicillin. Dexamethasone was discontinued. Debridement of the involved sinuses and adjacent structures was attempted together with diluted amphotericin B irrigation. Orbital exenteration was discussed but it was not retained due to poor prognosis and lack of the patient's consent.

Over the following days, the patient's ocular and general conditions worsened due to bilateral extensive eyelid and facial necrosis with purulent melting of the left eyeball and central nervous system involvement (Fig. 4) . He passed away at day 30.

With the onset of COVID-19 pandemic, clinicians have seen a sudden surge of cases of mucormycosis. Although all ocular structures may be involved in patients with COVID-19 infection, orbital mucormycosis seems to be the most aggressive and so far fatal complication [1] [2] [3] .

To the best of our knowledge very few cases of severe bilateral blindness in Covid-19 patient have been reported [2] [3] [4] [5] [6] . They were related either to orbital location of mucormycosis [2, 3] or to neurological complications including bilateral optic neuritis [4] and occipital ischemic stroke [5, 6] . The presentation of our patient suggests a left cavernous sinus and internal carotid thrombosis together with a right CRAO. From the ophthalmic and other orbital arteries, fungal infection advanced into the left cavernous sinus, ipsilateral carotid artery and right central retinal artery. This resulted in acute onset of bilateral vision loss and left ophthalmoplegia.

Successful treatment of ROCM highly depends on the early diagnosis of the infection, the control of the underlying predisposing factors and aggressive surgery [7] .

Hence, Ophthalmologists should have a high index of suspicion for mucormycosis development in diabetic patients with COVID-19 illness, treated with corticosteroids. Vaccination against SARS-COv2 seems to be the best treatment to prevent COVID-19 and related blinding and fatal diseases. 

We did not receive any funding.

For data, please refer to corresponding author.

Ethics approval and consent to participate This brief report has been performed in accordance with the ethical standards as laid down in 1964 by the declaration of Helsinki and its later amendments. Anonymous case reports are approved by the ethics committee of our institution as long as written consent is obtained from the patients.

COVID-19 and eye: a review of ophthalmic manifestations of COVID-19

Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: a case report

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 1-5. Advance online publication

Acute blindness as a complication of severe acute respiratory syndrome Coronavirus-2

Severe bilateral vision loss in 2 patients with coronavirus disease 2019

Sudden bilateral vision loss in a COVID-19 patient: a case report

Code Mucor: guidelines for the diagnosis, staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the setting of COVID-19